ACLARIS THERAPEUTICS INC (ACRS) Institutional Ownership Changes & 13F Activity

ACLARIS THERAPEUTICS INC (ACRS). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCSell-622,700502,631$1,884,866
Q4 2025Renaissance Technologies LLCSell-494,4001,125,331$3,387,246
Q3 2025Renaissance Technologies LLCBuy154,9531,619,731$3,077,489
Q2 2025Renaissance Technologies LLCBuy513,3841,464,778$2,079,985
Q1 2025Renaissance Technologies LLCBuy100,875951,394$1,455,633
Q4 2024Renaissance Technologies LLCSell-520,181850,519$2,109,287
Q3 2024Renaissance Technologies LLCBuy448,5001,370,700$1,576,305
Q2 2024Renaissance Technologies LLCSell-751,200922,200$1,014,420
Q1 2024Renaissance Technologies LLCSell-73,0321,673,400$2,075
Q4 2023Renaissance Technologies LLCBuy1,098,7801,746,432$1,834
Q3 2023Renaissance Technologies LLCSell-321,900647,652$4,436
Q2 2023Renaissance Technologies LLCSell-282,600969,552$10,054
Q1 2023Renaissance Technologies LLCBuy130,4001,252,152$10,130
Q4 2022Renaissance Technologies LLCSell-63,4261,121,752$17,668
Q3 2022Renaissance Technologies LLCSell-144,5001,185,178$18,655
Q2 2022Renaissance Technologies LLCSell-127,9001,329,678$18,562
Q1 2022Renaissance Technologies LLCSell-219,3001,457,578$25,129
Q4 2021Renaissance Technologies LLCSell-344,0001,676,878$24,382
Q3 2021Renaissance Technologies LLCSell-411,0002,020,878$36,376
Q2 2021Renaissance Technologies LLCSell-554,6002,431,878$42,704
Q1 2021Renaissance Technologies LLCSell-281,7002,986,478$75,259
Q4 2020Renaissance Technologies LLCSell-165,2123,268,178$21,145
Q3 2020Renaissance Technologies LLCBuy153,5503,433,390$8,824
Q2 2020Renaissance Technologies LLCBuy104,2043,279,840$5,313
Q1 2020Renaissance Technologies LLCBuy393,3393,175,636$3,303
Q4 2019Renaissance Technologies LLCBuy813,5812,782,297$5,259
Q3 2019Renaissance Technologies LLCBuy1,269,1361,968,716$2,126
Q2 2019Renaissance Technologies LLCBuy272,200699,580$1,532
Q1 2019Renaissance Technologies LLCBuy331,700427,380$2,560
Q4 2018Renaissance Technologies LLCBuy66,78095,680$707

Frequently asked questions about ACRS activity

  • Which institutional owners are buying ACRS?

    Institutional owners buying ACRS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ACRS activity?

    "Buy" means an investor increased their reported position in ACRS compared to the prior reporting period. This reflects growing exposure to ACLARIS THERAPEUTICS INC (ACRS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ACRS increasing?

    Institutional interest in ACRS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related ACRS Institutional Insights